Launching a New Category for Non-Surgical Skin Rejuvenatione
Ep. 89 - Jason Richey of Cytrellis
34 minute view/listen
How often does a genuinely novel aesthetic device make it past product-launch hurdles to make it into practices across the country?
Enter Jason Richey, President & CEO of Cytrellis Biosystems, to tell us about the nascent success of the Ellacor Micro-Coring system — the first of its kind to receive FDA clearance.
The brainchild of Cytrellis Founders Dr. Rox Anderson and Dr. Jay Austen, the Ellacor device uses hollow needles to remove "micro-cores" of skin less than .5 millimeters in diameter, causing the body's natural healing response to go into effect. Up to 8% of the skin in the treatment area can be removed, with the goal of improving skin architecture by allowing the skin to realign to close the cores.
Currently cleared for facial procedures, the device purports to fill a need for patients for patients interested in tightening and rejuvenating skin without a facelift.
With 120 devices installed as of the taping of this episode, and a goal of 300 installs by year-end, the future is looking bright for Ellacor. Tune in to find out what the potential of a wide range of additional applications could mean for complimentary dermal rejuvenation procedures on the latest episode of The Technology of Beauty.
The Technology of Beauty
Produced and co-founded by Influx, The Technology of Beauty is the podcast of renowned plastic surgeon Dr. Grant Stevens. Tune in to hear interviews with the innovators and entrepreneurs and who are shaping the future of aesthetics from the industry side.